Efstathia Papada1, Charalampia Amerikanou1, Alastair Forbes2, Andriana C Kaliora3. 1. Department of Dietetics and Nutritional Science, School of Health Science and Education, Harokopio University, 70 El. Venizelou Ave, 17671, Athens, Greece. 2. Norwich Medical School, University of East Anglia, Bob Champion Building, James Watson Road, Norwich, NR4 7UQ, UK. 3. Department of Dietetics and Nutritional Science, School of Health Science and Education, Harokopio University, 70 El. Venizelou Ave, 17671, Athens, Greece. akaliora@hua.gr.
Abstract
PURPOSE: To assess the adherence to MD in patients with Crohn's disease (CD). METHODS: Outpatients with CD were enrolled in this protocol. Medical history, disease activity, dietary intake, habitual Mediterranean diet (MedDiet) score, anthropometric measurements and Inflammatory Bowel Disease Questionnaire (IBDQ) were recorded. Blood samples were collected for quantification of biochemical and inflammatory indices. RESULTS: A total of 86 patients with CD were enrolled: 41 in relapse (5 ≤ Harvey Bradshaw Index ≤ 14) and 45 in remission (Harvey Bradshaw Index ≤ 4). Adherence to MD was greater in patients with inactive disease. The MedDiet score correlated positively with the IBDQ (p = 0.008) and negatively with disease activity (p < 0.001). CONCLUSIONS: Adherence to Mediterranean diet is associated with improved quality of life in CD patients. Higher adherence to Mediterranean diet could be of importance in patients with CD to improve quality of life and reduce disease activity.
PURPOSE: To assess the adherence to MD in patients with Crohn's disease (CD). METHODS: Outpatients with CD were enrolled in this protocol. Medical history, disease activity, dietary intake, habitual Mediterranean diet (MedDiet) score, anthropometric measurements and Inflammatory Bowel Disease Questionnaire (IBDQ) were recorded. Blood samples were collected for quantification of biochemical and inflammatory indices. RESULTS: A total of 86 patients with CD were enrolled: 41 in relapse (5 ≤ Harvey Bradshaw Index ≤ 14) and 45 in remission (Harvey Bradshaw Index ≤ 4). Adherence to MD was greater in patients with inactive disease. The MedDiet score correlated positively with the IBDQ (p = 0.008) and negatively with disease activity (p < 0.001). CONCLUSIONS: Adherence to Mediterranean diet is associated with improved quality of life in CDpatients. Higher adherence to Mediterranean diet could be of importance in patients with CD to improve quality of life and reduce disease activity.
Entities:
Keywords:
Crohn’s disease; Disease activity; Inflammation; Mediterranean diet; Quality of life
Authors: Francesca De Filippis; Nicoletta Pellegrini; Lucia Vannini; Ian B Jeffery; Antonietta La Storia; Luca Laghi; Diana I Serrazanetti; Raffaella Di Cagno; Ilario Ferrocino; Camilla Lazzi; Silvia Turroni; Luca Cocolin; Patrizia Brigidi; Erasmo Neviani; Marco Gobbetti; Paul W O'Toole; Danilo Ercolini Journal: Gut Date: 2015-09-28 Impact factor: 23.059
Authors: David L Suskind; Ghassan Wahbeh; Stanley A Cohen; Christopher J Damman; Jani Klein; Kim Braly; Michele Shaffer; Dale Lee Journal: Dig Dis Sci Date: 2016-09-16 Impact factor: 3.199
Authors: Laura Guida; Francesca Maria Di Giorgio; Anita Busacca; Lucio Carrozza; Stefania Ciminnisi; Piero Luigi Almasio; Vito Di Marco; Maria Cappello Journal: Nutrients Date: 2021-02-26 Impact factor: 5.717
Authors: James D Lewis; Robert S Sandler; Carol Brotherton; Colleen Brensinger; Hongzhe Li; Michael D Kappelman; Scott G Daniel; Kyle Bittinger; Lindsey Albenberg; John F Valentine; John S Hanson; David L Suskind; Andrea Meyer; Charlene W Compher; Meenakshi Bewtra; Akriti Saxena; Angela Dobes; Benjamin L Cohen; Ann D Flynn; Monika Fischer; Sumona Saha; Arun Swaminath; Bruce Yacyshyn; Ellen Scherl; Sara Horst; Jeffrey R Curtis; Kimberly Braly; Lisa Nessel; Maureen McCauley; Liam McKeever; Hans Herfarth Journal: Gastroenterology Date: 2021-05-27 Impact factor: 33.883